Eli Lilly's pricing strategy for GLP-1 drugs is expected to have minimal margin impact, with BofA reaffirming a $900 price target.

Intel's shares soared as optimism around a federal investment swept Wall Street. The stock broke through resistance levels and has surged more than 25% on the week. Trump’s support has already ...